Showing results (6051-6060 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 14, 2012
Biochemical markers of impending psychosisEnzo Emanuele, Valentina Martinelli, Vera Abbiati, et al.Current Pharmaceutical Design|January 14, 2012
Cognitive remediation in the early course of schizophrenia: a critical reviewStefano Barlati, Luca De Peri, Giacomo Deste, et al.Current Pharmaceutical Design|January 14, 2012
Cognitive behavioral therapy in prodromal psychosisJean Addington, Catherine Marshall, Paul FrenchCurrent Pharmaceutical Design|January 14, 2012
Psychoeducation in subjects at elevated risk for psychosis--a critical reviewMarta Hauser, Georg JuckelCurrent Pharmaceutical Design|January 14, 2012
Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS studyGregor E Berger, Stephen J Wood, Margaret Ross, et al.Current Pharmaceutical Design|January 14, 2012
Philosophical issues in the prodromal phase of psychosisMatthew Broome, Paolo Fusar-PoliCurrent Pharmaceutical Design|January 26, 2012
Human serum albumin conjugated biomolecules for cancer molecular imagingMeng Yang, Susan Hoppmann, Luxi Chen, et al.Current Pharmaceutical Design|January 26, 2012
A concise review of current radiopharmaceuticals in tumor angiogenesis imagingXia Lu, Rong Fu WangCurrent Pharmaceutical Design|January 26, 2012
Recent advances on radionuclide labeled hypoxia-imaging agentsZejun Li, Taiwei ChuCurrent Pharmaceutical Design|January 26, 2012
Development of specific radiopharmaceuticals for infection imaging by targeting infectious micro-organismsGuillermina Ferro-Flores, Blanca E Ocampo-Garcia, Laura Melendez-AlafortPageof 1,008